Cholera - Pipeline Review, H2 2016 - Global Markets Direct - Market Research

Cholera - Pipeline Review, H2 2016

Cholera - Pipeline Review, H2 2016 - Global Markets Direct - Market Research
Cholera - Pipeline Review, H2 2016
Published Jul 13, 2016
45 pages — Published Jul 13, 2016
Price US$ 2,000.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Global Markets Directs, Cholera - Pipeline Review, H2 2016, provides an overview of the Cholera pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Cholera, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Cholera and features dormant and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the global therapeutic landscape of Cholera
- The report reviews pipeline therapeutics for Cholera by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved Cholera therapeutics and enlists all their major and minor projects
- The report assesses Cholera therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news related to pipeline therapeutics for Cholera

Reasons to buy

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Cholera
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Cholera pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective

  
Source:
Document ID
GMDHC8232IDB
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables41
  List of Figures41
Introduction51
  Global Markets Direct Report Coverage51
Cholera Overview61
Therapeutics Development72
  Pipeline Products for Cholera Overview71
  Pipeline Products for Cholera Comparative Analysis81
Cholera Therapeutics under Development by Companies91
Cholera Therapeutics under Investigation by Universities/Institutes101
Cholera Pipeline Products Glance113
  Late Stage Products111
  Clinical Stage Products121
  Early Stage Products131
Cholera Products under Development by Companies141
Cholera Products under Investigation by Universities/Institutes151
Cholera Companies Involved in Therapeutics Development162
  Beijing Minhai Biotechnology Co., Ltd161
  MSD Wellcome Trust Hilleman Laboratories, Pvt. Ltd.171
Cholera Therapeutics Assessment189
  Assessment by Monotherapy Products181
  Assessment by Target192
  Assessment by Mechanism of Action212
  Assessment by Route of Administration232
  Assessment by Molecule Type252
Drug Profiles2713
  cholera (trivalent) vaccine Drug Profile271
  cholera [strain O1/El/Tor/Ogawa] vaccine Drug Profile281
  cholera vaccine Drug Profile291
  Cholvax Drug Profile301
  crofelemer DR Drug Profile313
  gram-negative bacterial infections vaccine Drug Profile341
  IMSUTMR-1501 Drug Profile351
  Peptide for Cholera and Guillain-Barre Syndrome Drug Profile361
  Small Molecules for Bacterial Infections Drug Profile371
  Small Molecules to Inhibit Sialic Acid Permease for Gram Negative Bacterial Infections Drug Profile381
  Synthetic Peptides to Disrupt Cell Membrane for Bacterial and Fungal Infections Drug Profile391
Cholera Dormant Projects401
Cholera Discontinued Products411
Cholera Product Development Milestones422
  Featured News &Press Releases421
    Apr 27, 2016: Hilleman Laboratories Provides Phase I/II Update on Cholera Vaccine421
    Feb 03, 2015: Napo Files Brief on Appeal In Dispute With Salix422
Appendix442
  Methodology441
  Coverage441
  Secondary Research441
  Primary Research441
  Expert Panel Validation441
  Contact Us441
  Disclaimer451

Table Of Contents

Global Markets Direct - Market Research—Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information.

About the Author


Cite this Report

  
MLA:
Global Markets Direct - Market Research. "Cholera - Pipeline Review, H2 2016" Jul 13, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/Global-Markets-Direct-Market-Research/Cholera-Pipeline-Review-H2-2016-2088-16165>
  
APA:
Global Markets Direct - Market Research. (2016). Cholera - Pipeline Review, H2 2016 Jul 13, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/Global-Markets-Direct-Market-Research/Cholera-Pipeline-Review-H2-2016-2088-16165>
  
US$ 2,000.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.